
RFiD Discovery has introduced an automated contact‑tracing solution for hospitals that leverages Bluetooth Low Energy (BLE) wristbands for patients and BLE‑enabled ID badges for staff. The system captures proximity, duration, distance and location data in real time, feeding it into a central platform that generates alerts and detailed dashboards. Designed for quick deployment, it can operate as a standalone contact‑tracing tool or expand into broader real‑time location services such as asset tracking and patient flow optimization. The solution is already in use across more than 200 hospitals in the UK and Europe.
Hospitals have long wrestled with manual contact‑tracing, a labor‑intensive process that often misses fleeting interactions in busy wards. The rise of infectious threats, from seasonal flu to novel pathogens, has amplified the need for instantaneous exposure data. By automating proximity capture, RFiD Discovery’s solution eliminates human error and delivers a comprehensive interaction log, allowing infection‑prevention teams to act on precise, time‑stamped information rather than retrospective estimates.
The technology hinges on Bluetooth Low Energy, a low‑power protocol ideal for continuous monitoring in clinical environments. Patients wear lightweight wristbands while staff carry BLE‑enabled badges; a network of gateway readers and anchors maps every encounter, recording distance, duration and location. This data streams to a cloud‑based analytics platform that applies configurable risk rules, generating real‑time alerts and visual dashboards. Because the system plugs into existing hospital networks, implementation is swift, and the architecture can be extended to asset tracking, sterilization monitoring, and patient flow optimization, creating a unified location‑services ecosystem.
From a market perspective, the solution positions RFiD Discovery as a key player in the burgeoning digital‑health infrastructure space. With deployments in over 200 facilities, the company demonstrates scalability and credibility, appealing to health systems seeking to modernize infection control without overhauling legacy systems. As regulatory scrutiny on hospital‑acquired infections intensifies, automated tracing offers a tangible pathway to meet compliance, lower liability, and improve patient outcomes, likely spurring broader adoption across Europe and beyond.
Comments
Want to join the conversation?